Skip to content Skip to search Skip to footer
Washington University School of Medicine in St. Louis

The DOLF Project

Death to Onchocerciasis and Lymphatic Filariasis

Menu
  • About DOLF
    • Annual vs Semiannual Community MDA Studies
    • Albendazole Only for LF Studies
    • Soil Transmitted Helminths (STH) Studies
    • IDA for LF Studies
    • IDA for Onchocerciasis Studies
    • Moxidectin for LF Studies
    • Diagnostic Methods
  • Diseases
    • Lymphatic Filariasis (LF)
    • Onchocerciasis (Oncho)
    • Soil Transmitted Helminths (STH)
    • Loiasis (Loa loa)
  • Study Sites
    • Map of Study Sites
  • Our Team
    • Technical Advisory Team
    • Collaborating Institutions
  • Publications
  • Programs & Partnerships
  • News
  • Contact Us

Publications: IDA for Onchocerciasis Studies

Potential value of triple drug therapy with ivermectin, diethylcarbamazine, and albendazole (IDA) to accelerate elimination of lymphatic filariasis and onchocerciasis in Africa
Fischer PU, King CL, Jacobson JA, Weil GJ
PLoS Negl trop Dis. 2017;11(1):e0005

All DOLF Sponsored Publications

Death to Onchocerciasis Project & Lymphatic Filariasis (DOLF) Project

Principal investigator: Gary J. Weil, MD, Washington University in St. Louis

4444 Forest Park Avenue

St. Louis, Missouri 63108

  • Twitter

CONTACT US

dolfproject@wustl.edu

©2024 Washington University in St. Louis

Subscribe

Subscribe By Email

Get every new post delivered right to your inbox.

This form is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.